Cronos Group Stock Forecast, Price & News

Cronos Group's stock was trading at $5.41 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, CRON shares have increased by 96.9% and is now trading at $10.65.
View which stocks have been most impacted by COVID-19.

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cronos Group in the last year. There are currently 2 sell ratings, 4 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Cronos Group stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CRON, but not buy additional shares or sell existing shares.
View analyst ratings for Cronos Group or view MarketBeat's top 5 stock picks.

Wall Street analysts have given Cronos Group a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Cronos Group wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Cronos Group is scheduled to release its next quarterly earnings announcement on Monday, March 29th 2021.
View our earnings forecast for Cronos Group.

Cronos Group Inc. (NASDAQ:CRON) announced its earnings results on Thursday, November, 5th. The company reported $0.19 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.06) by $0.25. The business earned $11.36 million during the quarter, compared to analysts' expectations of $14.80 million. Cronos Group had a net margin of 266.31% and a negative trailing twelve-month return on equity of 1.61%. The company's quarterly revenue was up 96.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.62 EPS.
View Cronos Group's earnings history.

8 equities research analysts have issued 1 year target prices for Cronos Group's shares. Their forecasts range from $5.00 to $11.00. On average, they anticipate Cronos Group's stock price to reach $8.19 in the next twelve months. This suggests that the stock has a possible downside of 23.1%.
View analysts' price targets for Cronos Group or view Wall Street analyst' top-rated stocks.

Cronos Group saw a drop in short interest in the month of December. As of December 31st, there was short interest totaling 28,510,000 shares, a drop of 20.0% from the December 15th total of 35,620,000 shares. Based on an average daily volume of 5,370,000 shares, the short-interest ratio is currently 5.3 days. Currently, 15.7% of the shares of the company are sold short.
View Cronos Group's Short Interest.

Some companies that are related to Cronos Group include Canopy Growth (CGC), STADA Arzneimittel Aktiengesellschaft (STDAF), Aphria (APHA), Tilray (TLRY), USANA Health Sciences (USNA), Aurora Cannabis (ACB), HEXO (HEXO), Sundial Growers (SNDL), Canopy Rivers (RIV), ChromaDex (CDXC), Charlie's (CHUC), MediWound (MDWD), Natural Alternatives International (NAII), Glucose Health (GLUC) and True Drinks (TRUU).
View all of CRON's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group investors own include (CGC), Aurora Cannabis (ACB), Tilray (TLRY), (APHA), NVIDIA (NVDA), Advanced Micro Devices (AMD), Dollar Tree (DLTR), Micron Technology (MU), Alibaba Group (BABA) and OrganiGram (OGI).

Cronos Group trades on the NASDAQ under the ticker symbol "CRON."

Cronos Group's stock is owned by a number of institutional and retail investors. Top institutional investors include Kestra Advisory Services LLC (0.02%), Traynor Capital Management Inc. (0.01%), Kestra Private Wealth Services LLC (0.01%), International Assets Investment Management LLC (0.00%) and Global Retirement Partners LLC (0.00%). Company insiders that own Cronos Group stock include Jason Marc Adler, Michael Ryan Gorenstein and Todd Kevin Abraham.
View institutional ownership trends for Cronos Group.

CRON stock was acquired by a variety of institutional investors in the last quarter, including Traynor Capital Management Inc., Kestra Advisory Services LLC, International Assets Investment Management LLC, Kestra Private Wealth Services LLC, and Global Retirement Partners LLC.
View insider buying and selling activity for Cronos Group or or view top insider-buying stocks.

Shares of CRON can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of CRON stock can currently be purchased for approximately $10.65.

Cronos Group has a market capitalization of $3.79 billion and generates $25.64 million in revenue each year. The company earns $1.17 billion in net income (profit) each year or $0.67 on an earnings per share basis. Cronos Group employs 631 workers across the globe.

The official website for Cronos Group is www.thecronosgroup.com.

Cronos Group's mailing address is 111 PETER STREET SUITE 300, TORONTO A6, M5V 2G9. The company can be reached via phone at 416-504-0004.